Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.47 |
| ▸ | CASP1 | P29466 | 3/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.38 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.38 |
| ▸ | KDR | P35968 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | AURKA | O14965 | 1/20 | 0.38 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.38 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18682060 | 1.00 | CYP3A4 (0.47) | CYP3A4CASP1RECQLCHRNB2CHRNA4 | |
| SCHEMBL23567922 | 0.92 | CYP3A4 (0.48) | CYP3A4CASP1RECQLCHRNB2CHRNA4 | |
| SCHEMBL807465 | 0.92 | CYP3A4 (0.48) | CYP3A4CASP1RECQLCHRNB2CHRNA4 | |
| SCHEMBL29549133 | 0.92 | CYP3A4 (0.48) | CYP3A4CASP1RECQLCHRNB2CHRNA4 | |
| SCHEMBL29636243 | 0.92 | CYP3A4 (0.48) | CYP3A4CASP1RECQLCHRNB2CHRNA4 | |
| SCHEMBL17789217 | 0.85 | ACHE (0.46) | CYP3A4CASP1RECQLCHRNB2CHRNA4 | |
| SCHEMBL17678877 | 0.83 | ALDH1A1 (0.54) | CYP3A4CASP1RECQLCHRNB2CHRNA4 | |
| SCHEMBL29457161 | 0.80 | CYP3A4 (0.37) | CYP3A4CASP1RECQLCHRNB2CHRNA4 | |
| SCHEMBL19307997 | 0.80 | ACHE (0.42) | CYP3A4CASP1RECQLCHRNB2CHRNA4 | |
| SCHEMBL807463 | 0.75 | CHRNB2 (0.39) | CYP3A4CASP1RECQLCHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115852512-A | Polyimide fiber and preparation method thereof | 江苏先诺新材料科技有限公司 | 2023-03-28 | — | — | CN | claimed |
| US-11742152-B2 | Organic triptycene-based molecules having one or more arylene diimide groups attached forming a crosslinked framework useful for lithium ion battery electrodes | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2023-08-29 | — | — | US | disclosed |
| WO-2023068656-A1 | SECONDARY BATTERY INCLUDING POUCH WITH GAS ADSORBENT INTERPOSED THEREIN AND METHOD FOR MANUFACTURING SAME | 주식회사 엘지에너지솔루션 | 2023-04-27 | — | — | WO | disclosed |
| CN-115852512-A | Polyimide fiber and preparation method thereof | 江苏先诺新材料科技有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-20210167388-A1 | ORGANIC TRIPTYCENE-BASED MOLECULES HAVING ONE OR MORE ARYLENE DIIMIDE GROUPS ATTACHED FORMING A CROSSLINKED FRAMEWORK USEFUL FOR LITHIUM ION BATTERY ELECTRODES | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2021-06-03 | — | — | US | disclosed |
| EP-2616493-B1 | POLYMERISATION METHOD | UNIV COURT UNIV OF EDINBURGH (GB) | 2020-07-01 | — | — | EP | disclosed |
| EP-3411080-A2 | COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES | Arrakis Therapeutics, Inc. (US) | 2018-12-12 | — | — | EP | disclosed |
| US-9840514-B2 | Dianhydrides, polyimides, methods of making each, and methods of use | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2017-12-12 | — | — | US | disclosed |
| WO-2017136450-A2 | COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES | ARRAKIS THERAPEUTICS, INC. (US) | 2017-08-10 | — | — | WO | disclosed |
| US-9458376-B2 | Electrochromic iptycenes | POLISHAK BRENT M (US) | 2016-10-04 | — | — | US | disclosed |
| US-9458376-B2 | Electrochromic iptycenes | POLISHAK BRENT M (US) | 2016-10-04 | — | — | US | disclosed |
| US-20160152630-A1 | DIANHYDRIDES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2016-06-02 | — | — | US | disclosed |
| US-20160137914-A1 | ELECTROCHROMIC IPTYCENES | POLISHAK BRENT M (US) | 2016-05-19 | — | — | US | disclosed |
| US-20160137914-A1 | ELECTROCHROMIC IPTYCENES | POLISHAK BRENT M (US) | 2016-05-19 | — | — | US | disclosed |
| US-9018270-B2 | Method for producing polymers comprising multiple repeat units of bicyclic diamines | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2015-04-28 | — | — | US | disclosed |
| WO-2015001422-A2 | DIANHYDRIDES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2015-01-08 | — | — | WO | disclosed |
| US-20130267616-A1 | Polymerisation Method | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2013-10-10 | — | — | US | disclosed |
| US-20130267616-A1 | Polymerisation Method | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2013-10-10 | — | — | US | disclosed |
| WO-2012035327-A1 | POLYMERISATION METHOD | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160152630-A1 | DIANHYDRIDES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE | ALKBH3, ALK, DDC | CYP3A4 2346/4885CASP1 3228/4885RECQL 1389/4885 |
| US-20160137914-A1 | ELECTROCHROMIC IPTYCENES | IDH3A, EYA2, IDH2 | CYP3A4 1929/4885CASP1 4447/4885RECQL 3650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.